Fee-only advisors specializing in special needs trusts and benefits coordination.
Special needs financial planning is a combination of trust structure, benefits preservation, and intergenerational coordination. Simple inheritance can disqualify a beneficiary from SSI/Medicaid, costing hundreds of thousands of lifetime benefits. Properly-structured Special Needs Trusts (SNTs), ABLE accounts, and letters of intent require speciali
What our matched specialists handle
- My child will never be able to manage money — how do we provide lifetime support?
- What's the difference between a first-party and third-party SNT?
- ABLE accounts — when do they make sense vs a full SNT?
- My sibling's special-needs child is an inheritor — how do I structure gifts?
- Letter of intent — what should it cover?
- Who should be trustee — family, professional, or a pooled trust?
Tools & guides
Lifetime Special Needs Care Cost Projection Calculator
Project the full private cost of lifetime care — year by year, inflation-adjusted — and see the present-value funding gap your plan must close.
Special Needs Trust Funding Calculator
Estimate lifetime SNT funding need based on life expectancy, annual support needed, and benefits-preserved income.
Special Needs Financial Planning Guide
Detailed framework — rules, tradeoffs, and common mistakes.
Letter of Intent Template
The document that tells future trustees and caregivers everything they need to know. Section-by-section template.
SNT vs ABLE Account
Side-by-side comparison — when each tool applies and when to use both.
Who Should Be SNT Trustee?
Family, corporate, or pooled trust — costs, risks, and how to structure a successor chain.
What Can an SNT Pay For?
Trustee distribution guide: safe expenses, ISM rules, and the 2024 food rule change that affects every SNT.
Life Insurance for Special Needs Trusts
Why survivorship policies are the primary SNT funding vehicle — ownership setup, how much to carry, and the three professionals you need.
ABLE Account 2026: Rules, Limits, and the Age-46 Expansion
The January 2026 eligibility expansion opens ABLE accounts to millions of additional adults. Full guide to 2026 contribution limits, qualified expenses, SSI impact, and 529 rollover rules.
When Your Special Needs Child Turns 18: Financial Checklist
SSI deeming ends, Medicaid shifts, guardianship must be filed beforehand. Timeline checklist covering every deadline — from age 14 to the 18th birthday and beyond.
Disabled Adult Child (DAC) Social Security Benefits
When a parent retires or dies, a child with a disability may receive $1,000–$2,500/month on the parent's record. 2026 rules, SSI interaction, Medicaid impact, and planning guide.
IRA and 401(k) Beneficiary Planning for Special Needs Families
A stale beneficiary designation naming your special-needs child directly destroys their SSI and Medicaid. How to name the SNT instead, SECURE Act disabled EDB rules, and Roth IRA strategy.
Housing Options for Adults with Special Needs
Group home, supported living, ICF, or family home — each triggers different Medicaid, SSI, and SNT rules. Financial implications of each path, HCBS waiver basics, Section 8 strategy, and how to size your SNT around the housing plan.
How Much Does a Special Needs Trust Cost?
Attorney fees to draft an SNT run $1,500–$5,000+. Annual trustee and admin costs add $3,000–$15,000/year. Complete 2026 cost breakdown — setup, ongoing fees, pooled trust comparison, and how to keep costs proportionate.
SSI Work Incentives 2026: How Employment Affects Benefits
Working doesn't automatically end SSI or Medicaid. The SSI earned income formula, Student Earned Income Exclusion, IRWE, PASS plans, Section 1619(b) Medicaid protection, and ABLE to Work — complete 2026 guide.
Pooled Special Needs Trust: How It Works and the Retained-Remainder Gotcha
A lower-cost alternative to a standalone SNT — nonprofit-managed, no age limit for first-party accounts, and annual fees as low as $1,200/yr. But the retained-remainder clause can divert inheritance from your heirs. Full 2026 guide with cost comparison.
Special Needs Trust Taxes: Form 1041, 2026 Brackets, and Distribution Strategy
Your SNT is its own taxpayer and files Form 1041 every April. The problem: trust income hits the 37% bracket at just $16,000 — compared to $640,600 for individuals. 2026 guide to trust tax brackets, DNI and distributions, tax-efficient investing inside an SNT, and the SSI trade-off.
HCBS Medicaid Waiver: Services, Waitlists, and How to Apply
Home and community-based services waivers fund residential support, day programs, and respite care — but waitlists average 5–15 years. Why to enroll your child now, what services are covered, and how waiver funding changes your SNT sizing math.
Autism Financial Planning: ABA Therapy, the Age-21 Cliff, and SNT Strategy
ABA therapy can run $40,000–$80,000/year. IDEA school services end at 21. Adult autism support systems are underfunded and waitlisted. Condition-specific guide covering ABA cost planning through the SNT, HCBS urgency, ABLE for working autistic adults, and SSI work incentives.
Down Syndrome Financial Planning: SNT Sizing, Alzheimer's Planning, and a 60-Year Horizon
Adults with Down syndrome now live to an average age of 60, and more than 90% will develop Alzheimer's with mean clinical diagnosis at 54. A complete financial plan requires three-phase SNT sizing (community living, early Alzheimer's, memory care), legal decision-making frameworks before cognitive decline, and ABLE accounts for working DS adults.
Cerebral Palsy Financial Planning: Equipment Costs, SNT Strategy, and the GMFCS Spectrum
Power wheelchairs cost $12,000–$25,000+ and need replacement every 5 years. Selective dorsal rhizotomy runs $50,000–$100,000+. And many CP adults work — making SSI work incentives central, not peripheral, to the financial plan. Condition-specific guide covering equipment cost planning through the SNT, HCBS personal care waiver urgency, ABLE for working CP adults, and SNT sizing by GMFCS level.
Spina Bifida Financial Planning: Shunt Surgery Costs, SNT Strategy, and the Adult Care Cliff
VP shunt revisions occur throughout life — nearly half fail within two years. Neurogenic bladder requires lifelong catheter supplies and periodic urological surgery. And the transition to adult care at 18–21 creates a dangerous gap in coordinated medical management. Condition-specific guide covering the shunt revision reserve, neurogenic bladder cost planning, SNT sizing by lesion level, and ABLE accounts for working SB adults.
Epilepsy Financial Planning: AED Costs, SSI Listing 11.02, and SNT Strategy
About 30% of people with epilepsy have drug-resistant seizures that cannot be controlled with medication — and many cannot drive, limiting employment for decades. This guide covers SSI Listing 11.02 qualification criteria, AED medication costs (including $32,500–$45,000/year Epidiolex for Dravet syndrome), VNS and RNS device surgery costs, driving restrictions and employment planning, and how to structure SNTs and ABLE accounts around epilepsy's wide severity spectrum.
Psychiatric Disability Financial Planning: Schizophrenia, Bipolar Disorder, and SNT Strategy
Adults with schizophrenia, bipolar disorder, or other serious mental illness have unique planning needs: the person may have full legal capacity when stable yet be severely impaired during episodes, and roughly 50% have a co-occurring substance use disorder that shapes SNT distribution strategy. This guide covers SSA Blue Book 12.00 qualification criteria, SNT distribution discretion for psychiatric beneficiaries, ABLE accounts, representative payee coordination, guardianship vs. supported decision-making, housing options, and psychiatric advance directives in the letter of intent.
Traumatic Brain Injury Financial Planning: Settlement Proceeds, SNT Strategy, and VA Benefits
TBI is often sudden — a car accident, a fall, a combat injury — and the financial planning emergency begins before discharge. A personal injury settlement received in the wrong name destroys SSI and Medicaid eligibility instantly. This guide covers first-party SNT mechanics for settlement proceeds, SSA Listing 11.18 qualification criteria, VA disability compensation and TSGLI coordination for veterans, cognitive capacity tools (rep payee, authorized individual, guardianship vs. SDM), and SNT distribution language tailored to TBI's specific cost profile.
Muscular Dystrophy Financial Planning: SNT Strategy, Medication Costs, and Cardiomyopathy Planning
Duchenne muscular dystrophy involves one of the most expensive treatment landscapes of any disability category — exon-skipping therapies at $300,000–$1M+/year, gene therapy at $3.2M, and a planning horizon that has lengthened to 30–40 years with modern cardiac and respiratory care. This guide covers SNT sizing across the three phases of DMD adulthood, Elevidys gene therapy planning considerations (including the June 2025 FDA safety update), equipment cost modeling, HCBS technology-dependent waiver strategy, and SSI work incentives for Becker MD adults who work.
Visual Impairment and Blindness Financial Planning: SSI, SNT, and Assistive Technology
SSDI applies a higher SGA limit for blind workers — $2,830/month in 2026 versus $1,690 for other disabilities — giving substantially more earning room before benefits are at risk. And SSI offers a Blind Work Expense deduction available only to blind beneficiaries, allowing deduction of guide dog care, assistive tech, and transportation costs from countable income. This guide covers the unique Social Security rules for blind individuals, assistive technology cost planning through the SNT (braille displays, screen readers, guide dogs), ABLE accounts for working blind adults, and SNT distribution language for vision-specific expenses.
Hearing Loss and Deafness Financial Planning: SNT, Cochlear Implant Costs, and ABLE Accounts
Unlike blindness, hearing loss and deafness carry no elevated SSDI SGA — deaf SSDI recipients face the same $1,690/month threshold as all other non-blind disabled workers. Cochlear implant processor upgrades recur every 4–7 years at $5,000–$15,000 per ear, and traditional Medicare doesn't cover routine hearing aids. This guide covers hearing technology cost planning through the SNT, IRWE deductions for sign language interpreter and captioning costs at work, ABLE accounts for hearing-related expenses, and first-party SNT strategy for hearing loss caused by injury or malpractice.
Intellectual and Developmental Disability (ID/DD) Financial Planning: SNT, DD Waiver, and Lifetime Support
More than 607,000 individuals with ID/DD are on HCBS waiver waitlists nationally — and average wait times run 5–15 years. The SNT sizing math changes dramatically depending on whether a waiver slot is available: private residential care runs $40,000–$120,000/year, while waiver-covered residential leaves the SNT to fund only supplemental expenses. This guide covers HCBS DD waiver enrollment urgency, SNT sizing for multiple scenarios, SSI qualification under Blue Book Listing 12.05, ABLE accounts with authorized-individual management, and the age-21 IDEA cliff that hits every ID/DD family.
Multiple Sclerosis Financial Planning: SSDI Strategy, DMT Costs, and the Medicare Gap
Nearly 1 million Americans have MS — most diagnosed in working age. Financial planning for MS means managing a transition from full employment to SSDI, bridging the 24-month Medicare gap while covering $65,000–$110,000/year DMTs, and acting fast on life insurance before disease progression closes the window. This guide covers SSDI timing, the COBRA disability extension strategy, the 2026 Medicare Part D $2,100 OOP cap for oral DMTs, first-party SNT for settlement proceeds, and SNT sizing across relapsing-remitting, secondary progressive, and primary progressive MS trajectories.
Spinal Cord Injury Financial Planning: Settlement Trusts, VA Benefits, and SNT Sizing
A personal injury settlement received in the wrong name immediately destroys SSI and Medicaid eligibility — and the average SCI lifetime cost reaches $2.5M–$5.2M depending on injury level (NSCISC 2025). This guide covers first-party SNT establishment before settlement closes, SSDI fast-track approval under Listing 11.08A for complete cord transection, VA disability compensation ($3,938/month at 100% in 2026) and Special Monthly Compensation for paralysis, equipment cost planning through the SNT (power wheelchairs, accessible vehicles, home modifications), and HCBS physical disability waiver urgency.
Cystic Fibrosis Financial Planning: Trikafta Costs, SSDI, and Medicaid Strategy
Trikafta and Alyftrek cost approximately $370,000 per year — making insurance continuity the central financial risk in every CF plan. CFTR modulators have extended CF life expectancy toward near-normal, which means a Special Needs Trust established today may need to fund 50+ years of supplemental care. This guide covers Medicaid preservation under Section 1619(b) for working CF adults, SSDI qualification under Blue Book Listing 3.04, the COBRA disability extension bridge during the Medicare gap, life insurance and LTD strategy while health is stable, third-party SNT planning for parents, and lung transplant financial planning.
Fragile X Syndrome Financial Planning: SNT Strategy, Carrier Risk, and ABLE Accounts
Fragile X is the most common inherited cause of intellectual disability — and it creates a planning challenge no other disability shares: the grandparents or parents who are premutation carriers face their own health risks. Male carriers over 50 have up to a 40%+ risk of FXTAS, a progressive neurodegenerative disorder that affects their own long-term care needs and trustee capacity. Female carriers face 20–30% risk of premature ovarian insufficiency. This guide covers SNT sizing across the wide FXS severity spectrum, SSA qualification pathways, ABLE accounts for working FXS adults, and the FXTAS and FXPOI planning adjustments for the carrier family members supporting them.
Huntington's Disease Financial Planning: Insurance Window, SSDI, and SNT Strategy
Huntington's disease is autosomal dominant — and a positive genetic test can legally be used by life and disability insurers to decline coverage or charge rated premiums, because GINA does not cover those products. The window to secure life insurance and long-term disability coverage is before the test, not after. Once symptomatic HD is confirmed, SSA's Compassionate Allowance program approves SSDI in approximately 10 days. This guide covers the insurance-first sequencing strategy, GINA's exact scope and limits, SSDI fast-track under Listing 11.17, cognitive capacity planning before disease progression, SNT structure for HD families, ABLE accounts for HD adults on SSI, and the caregiving financial impact on spouses.
Sickle Cell Disease Financial Planning: SSDI, Gene Therapy Costs, and SNT Strategy
Two FDA-approved gene therapies — Casgevy ($2.2M) and Lyfgenia ($3.1M) — offer a functional cure for sickle cell disease, but only for patients whose Medicaid or insurance is intact when treatment begins. For working SCD adults on SSI, Section 1619(b) Medicaid protection allows earning well above the SGA threshold while keeping Medicaid — the gene therapy access pipeline — intact. This guide covers SSDI qualification under Blue Book Listing 7.05, the CMS Cell and Gene Therapy Access Model (covering ~84% of Medicaid SCD patients in 2026), Section 1619(b) strategy, insurance continuity around gene therapy, SNT planning for SCD families, and ABLE accounts for working adults.
Prader-Willi Syndrome Financial Planning: Hyperphagia, SNT Food-Control Strategy, and Specialized Housing
Prader-Willi syndrome creates a financial planning problem no other disability shares: the beneficiary's biggest threat is food. Hyperphagia — the neurological inability to feel full — means an SNT for a PWS beneficiary must never distribute cash, must pay all vendors directly, and must explicitly prohibit food-purchase access to the beneficiary. Specialized, food-secured group homes cost $60,000–$120,000+/year. This guide covers PWS-specific SNT distribution language, HCBS DD waiver urgency, ABLE account design cautions, SSA qualification under Blue Book Listings 12.05 and 12.11, life insurance sizing for an extended planning horizon, and emerging GLP-1 treatment cost planning.
Rett Syndrome Financial Planning: Daybue Costs, CAL Fast-Track, and SNT Strategy
Daybue (trofinetide), the first FDA-approved treatment for Rett syndrome, costs $375,000–$1.3 million per year depending on patient weight — making Medicaid preservation the central financial goal for every Rett family. Gene therapy (TSHA-102, FDA Breakthrough designation) is in Phase 1/2 trials with a BLA planned. This guide covers SSA Compassionate Allowance fast-track, Rett-specific SNT distribution language for AAC devices, music therapy, scoliosis reserves and gene therapy authorization, HCBS waiver urgency, and guardianship at 18.
Angelman Syndrome Financial Planning: CAL Fast-Track, SNT Strategy, and GTX-102
Angelman syndrome combines near-normal life expectancy with full-lifetime care needs — creating a 55-year planning horizon that most advisors have never modeled. SSA's Compassionate Allowance program enables approximately 10-day disability approval. GTX-102 (apazunersen) Phase 3 ASPIRE trial completed enrollment; data expected H2 2026. This guide covers SSI/CAL fast-track, AS-specific SNT distribution language (AAC devices, music therapy, scoliosis surgical reserve, gene therapy authorization), ABLE accounts with authorized-individual management, HCBS DD waiver urgency, and guardianship at 18.
Williams Syndrome Financial Planning: SNT Exploitation Protection, SVAS Cardiac Reserve, and Work Incentives
Williams syndrome's characteristic hypersociability — the genuine, neurologically-driven compulsion to befriend strangers and agree to requests — makes WS beneficiaries among the most financially vulnerable adults with a disability. SNT distribution language must explicitly require vendor-direct payments and limit cash access. SVAS affects ~75–80% of WS individuals; ~20% require open-heart surgery ($75K–$200K per procedure). With a near-normal life expectancy and no SSA Compassionate Allowance designation, Blue Book Listing 12.05 (Intellectual Disorder) is the qualification pathway. This guide covers exploitation-protective SNT design, cardiac surgical reserves, ABLE account management, Section 1619(b) for working WS adults, HCBS DD waiver urgency, and guardianship at 18.
Spinal Muscular Atrophy Financial Planning: Medicaid Preservation, Spinraza Costs, and SNT Strategy
Spinraza costs $375,000 per year. Evrysdi costs $340,000 per year. Itvisma (FDA-approved November 2025 for ages 2 and older) costs $2.59 million as a one-time dose. For any SMA family, Medicaid preservation is not one goal among many — it is the financial plan, because Medicaid is the access gate to the treatment keeping the disease from progressing. This guide covers SSDI Compassionate Allowance fast-track for Types 0 and 1, Section 1619(b) Medicaid protection for working SMA adults, newborn screening action steps, SNT sizing by care scenario, equipment costs by SMA type, ABLE-to-Work strategy, and the GINA insurance gap for Type 4 adults.
Ehlers-Danlos Syndrome Financial Planning: SSDI Challenges, PT Costs, and SNT Strategy
EDS creates a financial planning problem where the external appearance often doesn't match the internal reality — many people with EDS look healthy while managing joint instability, chronic pain, and out-of-pocket medical costs of $10,000–$30,000+ per year. Vascular EDS (vEDS) carries life-shortening arterial risk that makes life insurance and estate planning an immediate priority after diagnosis. This guide covers SSDI eligibility under Blue Book Listing 1.18 and the RFC approach, the hEDS documentation challenge, the inherited-condition trustee succession problem, Section 1619(b) and IRWE deductions for working EDS adults, ABLE accounts, and SNT strategy for families and individuals across the hEDS, cEDS, and vEDS spectrum.
Tuberous Sclerosis Complex Financial Planning: Everolimus Costs, SSDI, and SNT Strategy
TSC's financial planning challenge is as variable as the condition itself — from mild (controlled epilepsy, normal IQ, full employment) to severe (refractory epilepsy, intellectual disability, multiple organ tumors requiring everolimus at $200,000+/year). Medicaid preservation is central when everolimus or sirolimus is required. This guide covers SSDI qualification via epilepsy (Listing 11.02), intellectual disorder (12.05), and autism (12.10) pathways; SNT sizing across the TSC severity spectrum; kidney disease planning for renal AMLs; LAM and lung transplant planning for female TSC adults; and ABLE accounts for higher-functioning TSC adults using Section 1619(b).
PKU Financial Planning: Medicaid Preservation, Palynziq Costs, and SNT Strategy
The September 2024 food ISM rule change allows a Special Needs Trust to pay directly for a PKU beneficiary's metabolic formula without reducing SSI — reversing the previous penalty that forced complex workarounds. Palynziq (expanded to adolescents ages 12+ in March 2026) costs several hundred thousand dollars per year, making Medicaid preservation central to every classic PKU plan. This guide covers the food ISM change and what it means for existing SNTs, Section 1619(b) Medicaid protection for working PKU adults, state insurance mandate gaps for metabolic food coverage, PKU-specific SNT distribution language (including a gene therapy authorization clause), ABLE accounts for working PKU adults, and the newborn screening planning sequence for families receiving a fresh diagnosis.
ADHD Financial Planning: SSI, ABLE Accounts, and Benefits Coordination
ADHD is the most common neurodevelopmental disorder — and most people with ADHD manage their finances independently. But for adults with severe ADHD, co-occurring anxiety or learning disabilities, or unstable employment history, the benefits planning challenges are specific and often missed by generalists. This guide covers SSA qualification under Blue Book 12.11, ABLE accounts as the primary savings tool for working ADHD adults on SSI, Section 1619(b) Medicaid protection, IRWE deductions for ADHD medication and coaching, rep payee and supported decision-making structures, when an SNT is appropriate, and what parents planning a inheritance for an ADHD adult child must do before that inheritance arrives.
How matching works
Get matched with a specialist
Fee-only advisor with no commission conflict. Free match.
Special Needs Advisor Match is a matching service. We connect you with vetted fee-only financial advisors in our network — we don't manage money or provide advice ourselves. Advisors in our network are fiduciaries who charge transparent fees (not product commissions), and we match you based on your specific situation.